Kevin M. Slawin, Chief Technology Officer at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 63,127 shares at $19.27 ($1.2M) on 2016-08-15, disclosed to the SEC on 2016-08-17.
Open-market sale of $1.2M BLCM by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.27 | 29,000 | $559K | 45.9% |
| 2 | $19.27 | 34,127 | $658K | 54.1% |
| Total | $19.27 avg | 63,127 | $1.2M | 100% |
| Filing → |
| BLCM | SELL | 2016-09-23 | $936K | — | Filing → |
| BLCM | SELL | 2016-09-23 | $467K | — | Filing → |
| BLCM | SELL | 2016-09-20 | $92K | — | Filing → |